ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

July 6, 2007

In Brief; Burkitt, Epstein Will Divide Bristol-Myers Award; “Italian Nobel” Won By Columbia’s Sol Spiegelman

March 26, 1982

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

Collins Sworn In As NIH Director

September 4, 2009

Gastrointestinal SPORE To Be Recompeted

June 23, 1995

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997